pLKO-shp38 Citations (3)
Originally described in: p38MAPK plays a crucial role in stromal mediated tumorigenesis.Alspach E, Flanagan KC, Luo X, Ruhland MK, Huang H, Pazolli E, Donlin MJ, Marsh T, Piwnica-Worms D, Monahan J, Novack DV, McAllister SS, Stewart SA Cancer Discov. 2014 Mar 26. PubMed Journal
Articles Citing pLKO-shp38
Articles |
---|
Extracellular vesicles enhance oxidative stress through P38/NF-kB pathway in ketamine-induced ulcerative cystitis. Xi XJ, Zeng JJ, Lu Y, Chen SH, Jiang ZW, He PJ, Mi H. J Cell Mol Med. 2020 May 22. doi: 10.1111/jcmm.15397. PubMed |
miRNA-34c Suppresses Osteosarcoma Progression In Vivo by Targeting Notch and E2F. Bae Y, Zeng HC, Chen YT, Ketkar S, Munivez E, Yu Z, Gannon FH, Lee BH. JBMR Plus. 2022 Apr 9;6(5):e10623. doi: 10.1002/jbm4.10623. eCollection 2022 May. PubMed |
LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization. Hu J, Dong F, He Y, Xia X, Cheng F, Chen S, Hou X, Zhang P, Liu G, Li Y, Gao Q, Dong M, Li T, Li W, Xiao Q, Li X, Yu X, Xi G, Guo D, Wu X, Wang B. J Immunother Cancer. 2022 Sep;10(9):e004452. doi: 10.1136/jitc-2021-004452. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.